What angel diligence misses on technology
Angel diligence misses the software because the published checklists were written around management, market, money and legal, and treat technology as a line about IP. The Angel Capital Association's July 2007 best-practice guide on due diligence has sections on risk, planning, NDAs, reasons deals are rejected, site visits, references, and how much analysis to do, and none on the product or the code. The UK Business Angels Association's 2020 guide has a Technical heading with eight questions, every one of them about positioning, licensing, protection or market timing. This page reads both documents section by section, shows what they do cover well, and names the four technical questions an angel is left to ask alone.
Published September 17, 2026. Editorial.
Key takeaways
- The ACA's July 2007 due diligence guide is organised into eight sections and none of them is about the product, the code, or the people who wrote it; technology appears once, as a risk that it may not work in time.
- The UKBAA's September 2020 guide has a Technical section of eight questions, and all eight are about dependence, licensing, platform potential, IP protection, novelty, readiness, incumbents and trends rather than whether the software runs.
- The Golden Seeds playbook from 2010, hosted by the ACA, is the one angel document that names a technology assessment, and its instruction is to find an outside expert rather than to check anything directly.
- Four questions fall through every one of these documents: does the product run for real users, who can change it, what breaks when the founder is away, and what the AI claim means.
Angel diligence misses technology because the documents that define good practice for angels were written around four things an experienced business person can judge without help: the management team, the market, the financial projections, and the legal position. Software is treated as a subset of intellectual property, and intellectual property is treated as a legal question.
That is a fair description of how the field thinks, and it is why a non-technical angel ends up with no questions to ask about the product beyond "can I see a demo". This page goes through the two most cited documents to show exactly what is there and what is missing.
What does the ACA's 2007 due diligence guide cover?
The Angel Capital Association's "Best Practice Guidance for Angel Groups: Due Diligence" was written by David Eyler of Columbia University in July 2007 and remains the document the association points members to. Read in order, its sections are: Defining the Risk of the Investment Opportunity; When to Start Due Diligence; Creating a Due Diligence Plan; Non Disclosure Agreements; Reasons Deals are Rejected; a second Creating a Due Diligence Plan section covering the business plan, site visits and references; Gut vs. Brain, on how much analysis is appropriate; and a Conclusion.
Within those sections the guide is thorough about people. It tells a group to check credentials, run a legal background check, judge mindset, leadership, honesty and judgment. It quotes David Rose of New York Angels on asking references for more names, and John May of New Vantage Group, who "expects to have around 30 conversations" per deal. It is thorough about the market, the business model, the financial projections, the deal structure and the exit.
Technology appears in two places. Under "Creating a Due Diligence Plan", the first assumption to confirm is "Viability of IP", followed by three paragraphs from a patent lawyer about filing deadlines and claim scope. Under "Defining acceptable risks", the guide notes that "if the firm is developing a new technology, there is a risk that it won't work or, more likely, that it won't work in time to be relevant", and then says that ruling out every venture with that risk would eliminate some of the best deals.
That is the whole treatment. There is no section on the product, no question about whether it runs, no question about who wrote it, and no mention of code.
What do the UKBAA's eight technical questions ask?
The UK Business Angels Association published "The due diligence process" in September 2020. It says investors focus on five areas: Management, Finance, Legal, and Commercial, with Commercial split into market questions and a Technical heading. The Technical heading has eight numbered questions. In the order the document gives them, they ask:
- Whether it is a stand-alone technology or relies on other technology or businesses, and how reliant.
- Whether the company needs to license in technology from other providers.
- Whether it is a platform technology usable for many applications, and if so whether one application has been prioritised.
- Whether the technology can be protected by intellectual property rights, and how, and in which markets.
- Whether it is an incremental improvement or a disruptive innovation.
- Whether the technology is ready to go to market, and if not, what the major developmental obstacles are.
- Which major companies are active in the space and what they are working on.
- What the current technology trends are and whether the idea will be overtaken before it reaches market.
Every one of these is a good question. Every one is also a question about position: where the technology sits relative to other technology, other companies, IP law and the market clock. Question six comes closest to asking whether the software works, and it asks the founder to name obstacles rather than asking the investor to look.
The management section of the same document does contain one technical question in disguise. Its eighth point asks how long the team have known each other and what happens if one of them leaves. At pre-seed, where the team is often one developer, that is the bus factor question, and it is filed under management.
What does the one angel playbook that names technology tell a group to do?
The Golden Seeds Due Diligence Playbook, dated January 2010 and hosted on the ACA's site, is the most operational angel document in circulation. It describes a deal team with roles for financial, sector expertise, marketing and "other, deal specific". In its Review section, the first assessment listed is technology, and the instruction reads: "Technology - need to obtain opinions from experts in the field. Some experts will be provided by the entrepreneur. We also need to dig amongst our networks to find our own."
The playbook's NDA section makes the same point from the other side. Angel groups do not sign NDAs, it says, with one exception: "we will sometimes want to have an expert (either inside or outside our group) help us evaluate a company's technology", and that expert may be asked to sign one.
So the most detailed angel process document treats technology as something to outsource to an expert. That is correct for a medical device. For a software startup at pre-seed, it means the group either has a member who writes code or it has no view at all. Assigning the technical reviewer in an angel group is about making that assignment deliberate.
Reveneau's angel review exists for the gap those three documents leave: it is a scoped check of whether the software runs, who can change it, and what the AI claim means, written up on one page for a deal lead who does not write code.
Why does the gap matter more now than in 2007?
Three things have changed since the ACA guide was written, and each makes the missing section more expensive.
The first is that the software is the company more often. In Wiltbank and Boeker's 2007 study of 1,137 angel exits, software was the largest industry at 19 percent of exits, followed by health and biotech at 18 percent. A 2007 checklist that covered technology through patents was covering a large share of its deals badly even then.
The second is that the product can now be built in weeks by one person with AI tools, which makes a convincing demo cheaper and a durable product no cheaper. The difference between the two is exactly what the checklists do not ask about. Demo versus production is the page for that.
The third is that the claim itself is now regulated. In March 2024 the SEC fined two advisers a combined $400,000 for AI statements they could not support, and in September 2024 the FTC brought five cases under Operation AI Comply. An angel who does not ask what the AI claim means is relying on the founder to have asked themselves.
What is left for the angel to ask alone?
Four questions fall through all three documents. They are the spine of this guide.
| Question | Where the checklists put it | What the angel has to do |
|---|---|---|
| Does the product run for real users? | Nowhere; "Is the technology ready to go to market?" asks the founder to say so | Watch it on a real account, live |
| Who can change the product? | Management, as "what happens if one leaves" | Read the commit history and ask who else can deploy |
| What breaks when the founder is away? | Nowhere | Ask what is written down |
| What does "we use AI" mean? | Nowhere | Ask for the test |
None of these needs code access and none needs a technical reviewer. The one-hour technical check turns them into a timed script. For the full version of what a checklist should contain on a larger deal, the technical due diligence checklist is the reference.
Does this mean the published checklists are wrong?
No. Both documents say true things about the parts of a deal they cover, and the ACA guide's advice on references, site visits and proportionality is as good now as it was in 2007. Its own "Gut vs. Brain" section quotes John May's view that analysis should be proportionate to the stage, "later = more", and that is the right frame for an angel: a pre-seed technical check should take an hour, and a Series B one should take weeks.
What the documents lack is the hour. This guide supplies it, and the pillar page puts the hour in the context of everything else an angel checks. Why the hours you spend on diligence matter is the evidence that the hour is worth spending.
Best for
- An angel who has used the ACA or UKBAA checklist and wants to know what it left out
- An angel group updating its diligence template
- A syndicate lead explaining to members why the technical questions are separate
Avoid if
- You already have a technical reviewer with a written scope, in which case go to the one-hour check
- The deal is a hardware or biotech company where the technology question is an expert question by nature
Verify before you commit
- Open the ACA 2007 guide and confirm its section headings contain no product or code section
- Count the UKBAA Technical questions and check that none asks whether the software runs
- Ask your group which member answered the technology question on the last three deals, and how
Common questions
Does the ACA due diligence guide have a technology section?
No. The Angel Capital Association's Best Practice Guidance for Angel Groups on due diligence, written by David Eyler in July 2007, is organised into sections on defining risk, when to start, creating a plan, NDAs, reasons deals are rejected, site visits and references, and how much analysis to do. Technology appears once as a risk that it may not work in time, and once as intellectual property.
What technical questions does the UKBAA due diligence checklist ask?
The UKBAA's September 2020 guide has eight technical questions: whether the technology is stand-alone or dependent, whether it needs licensing, whether it is a platform, whether it can be protected by IP, whether it is incremental or disruptive, whether it is ready for market, who the major companies in the space are, and what the trends are. None asks whether the software runs or who wrote it.
Why do angel checklists treat technology as an IP question?
Because the checklists were written by and for business investors, and IP is the part of technology a lawyer can assess. The ACA's 2007 guide lists "Viability of IP" as the first assumption to confirm and follows it with patent-filing advice. That works for a medical device with a patent at its centre and says nothing about a software product whose value is that it runs.
Is there any angel document that covers the technical review?
The Golden Seeds Due Diligence Playbook from January 2010, hosted by the ACA, lists technology as the first assessment in its review phase. Its instruction is to obtain opinions from experts in the field, some provided by the entrepreneur and some found through the group's own network. It describes who to ask rather than what to check.
Where does the bus factor question appear in the standard checklists?
Under management, in disguise. The UKBAA's 2020 management section asks how long the team have known each other and what happens if one of them leaves. At pre-seed, where the team is often a single developer, that is the question of whether the product survives the founder's absence, and it is worth asking as a technical question rather than a team one.
What technical questions should an angel ask that the checklists do not?
Four: does the product run for real users, who can change it, what breaks when the founder is away for a month, and what "we use AI" means in practice. None requires reading code. Each can be answered in a screen share by watching the product on a real account, scrolling the commit history, and asking for the written deployment steps and the AI test.
How much of angel investing is software?
In Wiltbank and Boeker's November 2007 study of 1,137 angel exits, software was the largest industry at 19 percent of exits, followed by health and biotech at 18 percent, business products and services at 16 percent, and consumer products and services at 15 percent. The ACA's 2026 Angel Funders Report added that nearly two-thirds of reporting groups made at least one AI-related investment in 2025.
Should an angel group rewrite its diligence template?
Add a technology page rather than rewriting the template. The existing sections on management, market, financials and legal are sound. What is missing is a one-page section with four questions, a named reviewer per deal, and a written scope. The ACA's 2007 guidance already says at least one member should have relevant domain experience and take the lead, so the structure is there.
Is a patent evidence that the software works?
No. A patent is a legal right over an idea and says nothing about whether the code that implements it runs for customers. The UKBAA's fourth technical question asks whether the technology can be protected by IP rights, which is worth knowing, and it is a different question from whether the product is in production. Ask both and keep them separate.
Why are the AI claim questions missing from angel checklists?
Because both documents predate the claims. The ACA guide is from 2007 and the UKBAA guide from September 2020. The regulatory actions that made the claim a diligence item came later: the SEC's March 2024 charges against Delphia and Global Predictions for AI statements, and the FTC's September 2024 Operation AI Comply with five cases including DoNotPay.
References
- Angel Capital Association, Best Practice Guidance for Angel Groups: Due Diligence, David Eyler, July 2007
- UK Business Angels Association, The due diligence process, September 2020
- Golden Seeds, Due Diligence Playbook, January 2010 (hosted by the Angel Capital Association)
- Wiltbank and Boeker, Returns to Angel Investors in Groups, Angel Capital Education Foundation, November 2007
- SEC, press release 2024-36, two investment advisers charged over AI statements, 18 March 2024
Related reading
How to prepare for technical due diligence before a raise or sale
Technical due diligence is where a deal can quietly fall apart. Here is what investors' technical reviewers actually look at, how to get ahead of it, and the red flags that scare them.
Technical due diligence for VC portfolio companies
Before you commit capital, you need a clear read on the code, the team, and the risk behind it. Here is what a real technical due diligence review covers.
More in Start here
Why the hours you spend on diligence matter
The hours an angel spends on due diligence are the one input with a measured link to returns. In "Returns to Angel Investors in Groups", published in November 2007 by Robert Wiltbank and Warren Boeker with support from the Kauffman Foundation, 539 angels in 86 groups reported 1,137 exits. The median angel spent 20 hours of diligence per investment. Angels above that median saw an overall multiple of 5.9X; angels below it saw 1.1X. Those who spent more than 40 hours saw 7.1X. The study has real limits: the hours are self-reported, it does not split them by type, and the data is from 2007. This page gives the exact figures and the limits together.
The one-hour technical check a non-technical angel can run alone
The one-hour technical check is a timed script that a non-technical angel can run in a single video call with the founder, without reading code and without a technical reviewer. It has six blocks: the product on a real account, the commit history, deployment, what the founder would rebuild, the AI claim, and security. Each block says what to ask, what to look at on the screen, and what a good and a bad answer looks like. It is written to be printed and taken into the meeting. It sits inside the 20 hours that the median angel in Wiltbank and Boeker's 2007 study spent on diligence, and it covers the four questions the standard angel checklists leave out.